GCIA
ITOS

Gabelli & Co Investment Advisers’s iTeos Therapeutics ITOS Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-146,450
Closed -$1.46M – 307
2025
Q2 		$1.46M Buy
+146,450
New +$1.18M 0.22% 83

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Gabelli & Co Investment Advisers's ITOS Position: Q3 2025 in Review

Gabelli & Co Investment Advisers sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 146,450 shares — an estimated $1.46M sold.

Gabelli & Co Investment Advisers first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $1.46M in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • Gabelli & Co Investment Advisers reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 146,450 iTeos Therapeutics shares in Q3 2025, an estimated $1.46M.
  • Gabelli & Co Investment Advisers first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's iTeos Therapeutics position peaked at $1.46M in Q2 2025.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2025, filed 12 Nov 2025.